GlassScriptPhysician profile
Matthew Hennig
NPI 1518127943
$5,519.65
in general payments reported to CMS, 2019-2025
19 companies · $2,072 in 2025
The $2,072 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $301 · 2021: $912 · 2022: $773 · 2023: $764 · 2024: $462 · 2025: $2,072.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,172 · Travel and Lodging: $1,125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,172.16 |
| Travel and Lodging | $1,124.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,124.81 | 2025 | |
| Medtronic, INC. | $940.96 | 2021-2025 | Endurant Iis, Venaseal |
| Astrazeneca Pharmaceuticals LP | $940.36 | 2021-2024 | Tagrisso, Imfinzi |
| Endologix LLC | $483.16 | 2019-2025 | Torus Stent Graft System, Endocross Device |
| Bard Peripheral Vascular, INC. | $434.02 | 2020-2022 | |
| W. L. Gore & Associates, INC. | $313.72 | 2022-2025 | Gore Tag Conformable Thoracic Endoprosthesis |
| Janssen Pharmaceuticals, INC | $291.50 | 2021-2022 | |
| Boston Scientific Corporation | $214.78 | 2020-2024 | Varithena Administration Pack |
| Terumo Medical Corporation | $174.38 | 2025 | Azur Cx Detachable |
| Teleflex LLC | $170.05 | 2025 | Manta |
| Penumbra, INC. | $146.63 | 2024 | Indigo System |
| Medtronic Vascular, INC. | $114.22 | 2020 | |
| Mindray Ds USA, INC. | $44.34 | 2025 | A7 Anesthesia System |
| Getinge USA Sales, LLC | $36.14 | 2022 | |
| Ambu INC. | $20.99 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $19.61 | 2020 | |
| Sanara Medtech INC. | $19.49 | 2023 | Celleraterx |
| Angiodynamics, INC. | $17.32 | 2021 | |
| Biocompatibles, INC. | $13.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Hennig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.